Boryung 미래 성장

Future 기준 확인 2/6

Boryung (는) 각각 연간 12.1% 및 12.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.4% 로 예상됩니다.

주요 정보

12.1%

수익 성장률

10.9%

EPS 성장률

Pharmaceuticals 수익 성장	33.3%
매출 성장률	12.4%
향후 자기자본 수익률	11.4%
애널리스트 커버리지	Low
마지막 업데이트	06 Nov 2024

최근 미래 성장 업데이트

Recent updates

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 09

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Jan 25

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Dec 23

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Nov 23

수익 및 매출 성장 예측

KOSE:A003850 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (KRW Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	1,312,000	82,000	N/A	72,000	1
12/31/2025	1,173,200	69,800	N/A	70,000	1
12/31/2024	1,041,000	64,900	N/A	131,000	1
9/30/2024	991,430	61,995	57,035	79,934	N/A
6/30/2024	928,718	64,579	40,051	63,399	N/A
3/31/2024	889,416	52,254	51,610	78,166	N/A
12/31/2023	859,626	40,203	19,169	42,224	N/A
9/30/2023	829,854	28,267	-120,022	-3,357	N/A
6/30/2023	819,463	38,284	-75,467	43,689	N/A
3/31/2023	785,679	42,063	-94,393	24,794	N/A
12/31/2022	760,476	41,894	-95,181	27,814	N/A
9/30/2022	724,659	53,911	2,909	66,442	N/A
6/30/2022	694,170	52,524	-37,854	22,893	N/A
3/31/2022	661,948	34,380	-24,301	37,032	N/A
12/31/2021	627,279	43,044	957	60,167	N/A
9/30/2021	600,008	41,823	31,493	51,816	N/A
6/30/2021	587,350	28,892	-1,699	56,164	N/A
3/31/2021	571,594	38,370	4,515	58,667	N/A
12/31/2020	561,867	26,856	-10,655	44,741	N/A
9/30/2020	562,433	27,744	-7,870	46,515	N/A
6/30/2020	546,974	27,969	25,017	46,561	N/A
3/31/2020	539,742	31,678	9,933	35,068	N/A
12/31/2019	524,269	32,222	-20,246	46,999	N/A
9/30/2019	498,006	32,950	-31,145	57,203	N/A
6/30/2019	480,242	29,886	-54,429	45,294	N/A
3/31/2019	467,445	22,830	-55,631	47,848	N/A
12/31/2018	460,402	20,307	-17,507	38,914	N/A
9/30/2018	441,580	64,630	-45,289	24,718	N/A
6/30/2018	440,087	62,855	N/A	26,833	N/A
3/31/2018	434,565	60,451	N/A	-12,386	N/A
12/31/2017	422,721	56,699	N/A	-24,614	N/A
9/30/2017	426,554	-3,202	N/A	-31,392	N/A
6/30/2017	423,777	-2,977	N/A	-33,281	N/A
3/31/2017	420,133	5,020	N/A	402	N/A
12/31/2016	409,140	5,614	N/A	9,363	N/A

애널리스트 미래 성장 예측

수입 대 저축률: A003850 의 연간 예상 수익 증가율( 12.1% )이 saving rate( 2.7% 보다 높습니다. ).

수익 vs 시장: A003850 의 연간 수익( 12.1% ) KR 시장( 28.4% 보다 느리게 성장할 것으로 예상됩니다. 28.4% 연간).

고성장 수익: A003850 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: A003850 의 수익(연간 12.4% ) KR 시장( 9.4% 보다 빠르게 성장할 것으로 예상됩니다. 9.4% 연간).

고성장 수익: A003850 의 수익(연간 12.4% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: A003850 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.4 %).

Boryung 미래 성장

Future 기준 확인 2/6

주요 정보

최근 미래 성장 업데이트

Price target decreased to ₩15,500

Price target increased to ₩17,500

Price target raised to ₩21,000

Price target raised to ₩21,000

Recent updates

Dividend of ₩100.00 announced

We Think Boryung (KRX:003850) Is Taking Some Risk With Its Debt

Investor sentiment improves as stock rises 18%

Earnings Not Telling The Story For Boryung Corporation (KRX:003850)

Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

Full year 2023 earnings: EPS misses analyst expectations

Boryung Corporation, Annual General Meeting, Mar 26, 2024

Upcoming dividend of ₩100.00 per share at 0.9% yield

Boryung Corporation(KOSE:A003850) dropped from KOSPI 200 Index

Investor sentiment improves as stock rises 17%

New major risk - Revenue and earnings growth

Boryung Corporation Partners with Axiom Space and Aurelia Institute to Launch the "2023 Humans in Space" Program

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ₩100.00 per share

Less than half of directors are independent

Price target decreased to ₩15,500

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Upcoming dividend of ₩75.77 per share

Price target increased to ₩17,500

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ₩400 (vs ₩180 in 1Q 2020)

Investor sentiment deteriorated over the past week

A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Full year 2020 earnings released: EPS ₩554 (vs ₩698 in FY 2019)

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Boryung Pharmaceutical Co., Ltd., Annual General Meeting, Mar 26, 2021

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

New 90-day high: ₩20,500

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Market pulls back on stock over the past week

Price target raised to ₩21,000

New 90-day high: ₩20,700

Market bids up stock over the past week

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Third quarter 2020 earnings released: EPS ₩168

New 90-day low: ₩14,750

New 90-day low: ₩15,250

Price target raised to ₩21,000

First half earnings released

New 90-day high - ₩17,550

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견